The role of circulating microRNA's in Endometriosis


The role of circulating microRNA's in Endometriosis

Increased circulating miR-370-3p regulates Steroidogenic Factor 1 in Endometriosis

Key Points

Highlight:

  • miR-370-3p suppresses proliferation of endometriotic cells by regulating SF-1 . 

Importance:

  • The use of miR-370-3p to regulate SF-1 may provide a new therapeutic strategy for endometriosis.

Background:

  • SF-1 is an essential transcriptional regulator coordinately regulating multiple genes involved in estrogen biosynthesis.
  • SF-1 also plays an extraordinarily important role in the pathogenesis of endometriosis, but the underlying mechanism is not fully understood.
  • Recently, miR-370 was reported to function as a tumor suppressor by targeting genes in various cancer cells.
  • Here, Dr. Taylor group from Yale University identifies the interaction of SF-1 and miR-370 and determines whether miR-370 controlled the growth of endometriotic cells by regulating SF-1.

Key points:

  • The expression of SF-1 and miR-370-3p are inversely proportional to each other in women with endometriosis.
  • In primary endometriotic cells, miR-370-3p suppresses SF-1 expression.
  • miR-370-3p further regulates the expression of SF-1 downstream genes such as StAR and CYP19A1.
  • miR-370-3p inhibits cell proliferation and induces apoptosis in endometrial stromal cells.
  • miR-370-3p functions as a negative regulator of Steroidogenic Factor 1 (SF-1) and cell proliferation in endometriotic cells.

Lay Summary

Endometriosis is an estrogen-dependent disorder. This disease affects approximately 10% of reproductive-aged women and 20% to 50% of infertile women.

Steroidogenic factor 1 (SF-1) is an essential transcriptional regulator coordinately regulating multiple genes involved in estrogen biosynthesis. SF-1 is known to play an extraordinarily important role in the pathogenesis of endometriosis. However, the mechanisms that regulate SF-1 expression in endometriosis are not fully understood.

MicroRNAs (miRNAs) are small single-stranded non-coding RNAs that can play important regulatory roles in animals. Recently, miR-370 was reported to function as a tumor suppressor in various cancer cells. Previous studies indicated that miR-370 was decreased in the serum of patients with endometriosis. However, the functions and mechanisms of miR-370 in endometriosis remain unclear.

In this study, Dr. Hugh S. Taylor's group from Yale University identifies the interaction of SF-1 and miR-370 and determines whether miR-370 controlled the growth of endometriotic cells by regulating SF-1. The paper appeared in American Journal of Physiology, Endocrinology, and Metabolism.

Firstly, this group confirmed the significantly increased SF-1 expression in endometriotic lesions. From miRNA microarray expression profiling analysis data, they identified that SF-1 and miR-370-3p are inversely expressive in endometriosis. In primary endometriotic cells, miR-370-3p suppresses SF-1 expression and its further downstream genes such as StAR and CYP19A1. By performing apoptosis analysis, miR-370-3p overexpression significantly inhibits cell proliferation and induces apoptosis in endometrial stromal cells.

In summary, Dr. Taylor group found that miR-370-3p acts to suppress proliferation by regulating SF-1 in endometriotic cells. The authors believe that the use of miR-370-3p to regulate SF-1 may provide a new therapeutic strategy for endometriosis.


Research Source: https://www.ncbi.nlm.nih.gov/pubmed/30576245


Endometriosis SF-1 miR-370-3p Apoptosis Cell proliferation

DISCLAIMER

Endonews is designed to strictly highlight the most recently published scientific research that focuses on endometriosis. It is not designed to provide medical advice or an opinion on the best form of treatment. We highly stress the importance of not using this site as a substitute for seeking an experienced physician, which is highly recommended if you have any questions or concerns regarding your endometriosis needs. We believe in the consciousness of our reader to discriminate that research is different than "standard of care," and trust that they can keep in mind that here at Endonews, we summarize the newest peer-reviewed scientific medical literature, without bias.